HMB-45 and Melan-A are Useful in the Differential Diagnosis Between Granular Cell Tumor and Malignant Melanoma
@article{Gleason2007HMB45AM, title={HMB-45 and Melan-A are Useful in the Differential Diagnosis Between Granular Cell Tumor and Malignant Melanoma}, author={Briana C. Gleason and Alessandra F. Nascimento}, journal={The American Journal of Dermatopathology}, year={2007}, volume={29}, pages={22-27} }
Granular cell tumors (GCTs), especially if atypical or malignant, may share cytomorphologic and architectural features with malignant melanoma, when the latter shows granular cell change. In many cases, these neoplasms can be differentiated from each other on histologic grounds, but distinction may sometimes be challenging. By immunohistochemistry, both tumors are strongly positive for S-100 protein and frequently express other nonspecific markers such as CD68, NSE, and NKIC3. In the current…
37 Citations
Immunohistology of Melanocytic Neoplasms
- Medicine
- 2019
The use of immunohistochemistry (IHC) and the newer ancillary techniques to help determine the prognosis and, possibly, aid in screening for targeted therapies are discussed.
Cutaneous amelanotic signet-ring cell malignant melanoma with interspersed myofibroblastic differentiation in a young cat
- MedicineJournal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
- 2016
The diagnosis of malignant melanoma can be difficult because these tumors can be amelanotic and may contain diverse variants and divergent differentiations, of which the signet-ring cell subtype is…
Dermatofibroma-like granular cell tumour: a potential diagnostic pitfall.
- Medicine, BiologyPolish journal of pathology : official journal of the Polish Society of Pathologists
- 2016
Another case in a 62-year-old woman with atypical dermatofibroma-like GCT is reported, and histopathological features are discussed, and other tumours in which granular changes have been observed are reviewed.
Primary Urethral Malignant Melanoma in an Elder Woman Diagnosed by Urine Cytology
- Medicine
- 2020
The urinary cytology and immunohistochemistry were useful for the rapid and accurate diagnosis for the urethral MM in a 95-year-old Japanese woman.
Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study
- MedicineGenes
- 2022
The advent of a new marker such as PRAME is surely a step forward not only in the diagnostic approach, but also in the immunotherapeutic approach to MM, although it is shown that PRAME can also be expressed in the context of atypical lesions apart from MM and the diagnostic sensitivity and specificity are clearly lower.
Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
- MedicinePathology, research and practice
- 2018
Granular cell differentiation: A review of the published work
- MedicineThe Journal of dermatology
- 2017
T tumors with granular cell differentiation can present a diagnostic challenge either by mimicking alternative diagnoses, or by failing to exhibit architectural clues of the primary entity, thus requiring an immunohistochemical work‐up, so it is important to be aware of the various entities that have been reported to exhibit granularcell morphology.
Non-melanocytic mimics of melanoma: Part I: intraepidermal mimics
- MedicineJournal of Clinical Pathology
- 2008
In this review, the different features of the benign, pre-malignant and malignant intraepidermal non-melanocytic tumours and tumour-like lesions that can closely mimic intraepidersmal melanoma (melanoma in situ) are emphasised.
Primary malignant melanoma without melanosis of the colon
- MedicineIntestinal research
- 2019
A 50-year-old woman with PMM originating in the colon is diagnosed with colonic PMM and underwent laparoscopic low anterior resection and lymph node dissection and has been recurrence-free for > 2 years.
References
SHOWING 1-10 OF 58 REFERENCES
Immunoprofile of MITF, Tyrosinase, Melan-A, and MAGE-1 in HMB45-Negative Melanomas
- MedicineThe American journal of surgical pathology
- 2002
MAGE-1, melanocyte-specific transcription factor, tyrosinase, and Melan-A are useful markers in the diagnosis of malignant melanocytic lesions when HMB45 is negative, andMelanocyte- specific transcription factor is not a useful marker for desmoplastic melanoma.
Expression of Melanocytic Differentiation Markers in Malignant Melanomas of the Oral and Sinonasal Mucosa
- MedicineThe American journal of surgical pathology
- 2001
Results reveal that T311 is the most sensitive marker for sinonasal melanomas and closely approaches the sensitivity of anti-S-100 protein for oral mucosal melanomas.
Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation.
- Medicine, BiologyArchives of pathology & laboratory medicine
- 2004
The study expands the immunophenotype of GCT (S100, CD68, protein gene product 9.5, and inhibin-alpha) regardless of location and supports a neural origin.
An immunophenotypic survey of malignant melanomas
- Medicine, BiologyHistopathology
- 1993
An immunohistochemical study of 106 malignant melanoma specimens from 59 patients, using formalin‐fixed, paraffin‐embedded material, is reported, and one specimen showed α‐smooth muscle actin (αSMA) positivity.
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas
- Medicine, BiologyVirchows Archiv
- 1999
It is shown that angiomyolipomas express the melanocyte-associated antigens Melan-A and gp-100 at the protein and at the mRNA level, suggesting a true expression of these antigen rather than cross-reacting epitopes.
CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
- MedicineAmerican journal of clinical pathology
- 2002
It is believed that CD99 may be a helpful "positive" feature in the histopathologic diagnosis of AFX, and the first report of CD99 and PGP9.5 immunostaining in AFX is reported.
Microphthalmia Transcription Factor in the Immunohistochemical Diagnosis of Metastatic Melanoma: Comparison With Four Other Melanoma Markers
- MedicineThe American journal of surgical pathology
- 2001
Microphthalmia transcription factor may be a valuable addition to the marker panel used in diagnosing melanoma, in combination with S100, TYR, and the other markers, but it is not present in cases of desmoplastic melanomas.
Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors.
- Medicine, BiologyModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
- 1996
It is concluded that positive immunoreactivity for A1AT and CD68 in GCT may be a reflection of the intracytoplasmic accumulation of phagolysosomes and that it does not imply a histiocytic origin for this tumors.
KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas.
- MedicineAmerican journal of clinical pathology
- 1995
The results indicate that KP1 shows a relatively wide spectrum of immunoreactivity with malignant neoplasms of presumed non-histiocyte origin, thus arguing against its expected specificity and high value in diagnostic pathology.
Microphthalmia Transcription Factor Expression in Cutaneous Benign, Malignant Melanocytic, and Nonmelanocytic Tumors
- MedicineThe American journal of surgical pathology
- 2001
The results demonstrate that Mitf antibody expression is conserved in the majority of benign and malignant melanocytic lesions, and that it may be helpful in the diagnosis of primary melanocytical skin lesions.